Wide Ranks

GRAL

GRAIL, Inc.

17.45

Top Statistics
Market Cap 586 M Forward PE -1.15 Revenue Growth 38.30 %
Current Ratio 9.65 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.3110 Enterprise / Revenue -1.72 Price To Sales Trailing12 Months 4.98
Profitability
Profit Margins 0.00 % Operating Margins -640.47 %
Balance Sheet
Total Cash 853 M Total Cash Per Share 25.71 Total Debt 72 M
Total Debt To Equity 2.79 Current Ratio 9.65 Book Value Per Share 77.93
All Measures
Short Ratio 686.00 % Message Board Id finmb_321823804 Shares Short Prior Month 3 M
City Menlo Park Uuid 29546564-a6f8-352f-a054-8ba6790f8b80 Previous Close 17.52
First Trade Date Epoch Utc 1 B Book Value 77.93 Total Debt 72 M
Volume 756734 Price To Book 0.2239 Fifty Two Week Low 12.33
Total Cash Per Share 25.71 Total Revenue 117 M Shares Short Previous Month Date 1 B
Target Median Price 16.00 Max Age 86400 Recommendation Mean 3.00
Sand P52 Week Change 0.3133 Operating Margins -640.47 % Target Mean Price 16.00
Net Income To Common -2117465984 Ask 17.58 Implied Shares Outstanding 33 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 751070
Average Volume10days 751070 Total Cash 853 M Next Fiscal Year End 1 B
Revenue Per Share 3.54 Held Percent Insiders 0.1375 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 17.52
Target Low Price 16.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 14.22
Open 17.45 Dividend Yield 0.00 % State CA
Time Zone Short Name EST Trailing Eps -58.29 Day Low 17.29
Address1 1525 O’Brien Drive Shares Outstanding 33 M Price Hint 2
Target High Price 16.00 Website https://grail.com 52 Week Change 0.2775
Average Volume 748251 Recommendation Key hold Forward Eps 0.0000
Compensation As Of Epoch Date 1 B Quick Ratio 921.60 % Is_sp_500 False
Regular Market Day High 18.37 Profit Margins 0.00 % Debt To Equity 2.79
Fifty Two Week High 23.36 Day High 18.37 Shares Short 3 M
Regular Market Open 17.45 Industry Key diagnostics-research Bid 17.38
Earnings Growth 0.00 % Enterprise To Revenue -1.72 Revenue Growth 38.30 %
Shares Percent Shares Out 0.1125 Operating Cashflow -612563968 Currency USD
Time Zone Full Name America/New_York Market Cap 586 M Is_nasdaq_100 False
Zip 94025 Quote Type EQUITY Industry Diagnostics & Research
Long Name GRAIL, Inc. Regular Market Day Low 17.29 Held Percent Institutions 0.6711
Current Price 17.45 Enterprise To Ebitda 0.3110 Financial Currency USD
Current Ratio 9.65 Gross Margins -68.59 % Industry Disp Diagnostics & Research
Number Of Analyst Opinions 1 Country United States Float Shares 21 M
Two Hundred Day Average 14.97 Enterprise Value -201954672 Price To Sales Trailing12 Months 4.98
Forward PE -1.15 Regular Market Volume 756734 Ebitda -650012992
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection.

The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.

It is also developing minimal residual disease and other post-diagnostic tests.

The company was incorporated in 2015 and is based in Menlo Park, California.

GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.